Eargo Inc (DELISTED) (EAR:DL)
2.57
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Eargo Free Cash Flow (Quarterly): -14.76M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -14.76M |
| June 30, 2023 | -19.00M |
| March 31, 2023 | -21.46M |
| December 31, 2022 | -20.70M |
| September 30, 2022 | -14.46M |
| June 30, 2022 | -63.94M |
| March 31, 2022 | -21.29M |
| December 31, 2021 | -45.54M |
| Date | Value |
|---|---|
| September 30, 2021 | -23.26M |
| June 30, 2021 | -23.69M |
| March 31, 2021 | -10.68M |
| December 31, 2020 | -7.623M |
| September 30, 2020 | -5.338M |
| June 30, 2020 | -7.388M |
| March 31, 2020 | -10.77M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-63.94M
Minimum
Jun 2022
-5.338M
Maximum
Sep 2020
-20.66M
Average
-19.00M
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
| Ainos Inc | -1.358M |
| OpGen Inc | -3.030M |
| Zomedica Corp | 3.763M |
| LENSAR Inc | -0.525M |
| Intelligent Bio Solutions Inc | -2.926M |